BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31594672)

  • 21. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.
    Quaglino P; Ribero S; Osella-Abate S; Macrì L; Grassi M; Caliendo V; Asioli S; Sapino A; Macripò G; Savoia P; Bernengo MG
    Surg Oncol; 2011 Dec; 20(4):259-64. PubMed ID: 21145730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis.
    Burke EE; Portschy PR; Tuttle TM; Kuntz KM
    Ann Surg Oncol; 2016 Sep; 23(9):2772-8. PubMed ID: 27194553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases.
    Parvez E; Khosrow-Khavar F; Dumitra T; Nessim C; Bernard-Bédard É; Rivard J; Pravong V; Wang S; Gervais MK; Meterissian S; Dumitra S
    Ann Surg Oncol; 2023 Feb; 30(2):1195-1205. PubMed ID: 36282456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
    Fujisawa Y; Otsuka F;
    Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
    Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
    Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma.
    Lee JS; Durham AB; Bichakjian CK; Harms PW; Hayman JA; McLean SA; Harms KL; Burns WR
    Ann Surg Oncol; 2019 Feb; 26(2):386-394. PubMed ID: 30556118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
    Nagaraja V; Eslick GD
    Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Completion Lymphadenectomy in Positive Regional Lymph Nodes in Melanoma: A Meta-analysis.
    Macedo FI; Fayne RA; Azab B; Yakoub D; Möller MG
    J Surg Res; 2019 Apr; 236():83-91. PubMed ID: 30694783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
    Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
    McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
    J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
    Lin X; Sun W; Ren M; Xu Y; Wang C; Yan W; Kong Y; Balch CM; Chen Y
    J Surg Oncol; 2023 Dec; 128(8):1407-1415. PubMed ID: 37689989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    J Clin Oncol; 2018 Feb; 36(4):399-413. PubMed ID: 29232171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
    Hewitt DB; Merkow RP; DeLancey JO; Wayne JD; Hyngstrom JR; Russell MC; Gerami P; Balch CM; Bilimoria KY
    J Surg Oncol; 2018 Sep; 118(3):493-500. PubMed ID: 30098302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.
    G Lben K; Berberoğlu U; Altınyollar H; Kınaş V; Turanlı S
    J Cancer Res Ther; 2016; 12(2):840-4. PubMed ID: 27461661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.